Barings LLC Regeneron Pharmaceuticals, Inc. Transaction History

Barings LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $361,064 - $428,323	-629 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $25,531 - $30,161	-54 Reduced 7.91%	629 $351,000
Q1 2021 May 11, 2021	BUY	$446.73 - $548.2 $7,594 - $9,319	17 Added 2.55%	683 $323,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $2.51 Million - $3.19 Million	-5,252 Reduced 88.75%	666 $322,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $1.5 Million - $1.82 Million	2,762 Added 87.52%	5,918 $3.31 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $147,583 - $217,054	-439 Reduced 12.21%	3,156 $1.54 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $183,667 - $252,261	-670 Reduced 15.71%	3,595 $1.34 Million
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $273 - $318	1 Added 0.02%	4,265 $1.18 Million
Q2 2019 Aug 12, 2019	BUY	$299.6 - $414.82 $47,037 - $65,126	157 Added 3.82%	4,264 $1.34 Million
Q1 2019 May 08, 2019	BUY	$372.08 - $439.57 $885,550 - $1.05 Million	2,380 Added 137.81%	4,107 $1.69 Million
Q2 2018 Aug 03, 2018	BUY	$284.6 - $344.99 $491,504 - $595,797	1,727 New	1,727 $596,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

Stay updated on Barings LLC with notifications on news.